Innospec Inc. (NASDAQ:IOSP) Short Interest Down 10.8% in January

Innospec Inc. (NASDAQ:IOSP) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 289,000 shares, a decrease of 10.8% from the January 15th total of 324,000 shares. Approximately 1.2% of the company’s stock are short sold. Based on an average daily volume of 130,300 shares, the short-interest ratio is currently 2.2 days.

Innospec Trading Down 3.2 %

NASDAQ IOSP opened at $108.19 on Tuesday. Innospec has a 1-year low of $103.65 and a 1-year high of $133.71. The company has a market capitalization of $2.70 billion, a PE ratio of 18.88 and a beta of 1.09. The firm’s fifty day simple moving average is $111.79 and its 200-day simple moving average is $112.74.

Hedge Funds Weigh In On Innospec

Hedge funds have recently modified their holdings of the stock. Blue Trust Inc. increased its stake in shares of Innospec by 503.9% in the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock worth $96,000 after acquiring an additional 650 shares during the last quarter. nVerses Capital LLC increased its stake in shares of Innospec by 200.0% in the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 600 shares during the last quarter. Murphy & Mullick Capital Management Corp acquired a new position in Innospec during the fourth quarter worth $106,000. Covestor Ltd increased its position in Innospec by 13.9% during the fourth quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company’s stock worth $106,000 after buying an additional 118 shares during the last quarter. Finally, KBC Group NV increased its position in Innospec by 82.3% during the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock worth $136,000 after buying an additional 558 shares during the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Innospec from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 11th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.